These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25333035)

  • 1. Do metformin a real anticarcinogen? A critical reappraisal of experimental data.
    Anisimov VN
    Ann Transl Med; 2014 Jun; 2(6):60. PubMed ID: 25333035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin for cancer and aging prevention: is it a time to make the long story short?
    Anisimov VN
    Oncotarget; 2015 Nov; 6(37):39398-407. PubMed ID: 26583576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and longevity: antidiabetic biguanides as geroprotectors.
    Anisimov VN; Semenchenko AV; Yashin AI
    Biogerontology; 2003; 4(5):297-307. PubMed ID: 14618027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metformin, buformin, and phenformin on the post-initiation stage of chemically induced mammary carcinogenesis in the rat.
    Zhu Z; Jiang W; Thompson MD; Echeverria D; McGinley JN; Thompson HJ
    Cancer Prev Res (Phila); 2015 Jun; 8(6):518-27. PubMed ID: 25804611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin for Prevention and Treatment of Colon Cancer: A Reappraisal of Experimental and Clinical Data.
    Anisimov VN
    Curr Drug Targets; 2016; 17(4):439-46. PubMed ID: 25738299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects of use of antidiabetic biguanides for cancer prevention and treatment: results of preclinical studies].
    Anisimov VN; Popovich IG; Egormin PA; Tyndyk ML; Yurova MN; Osipov MA
    Vopr Onkol; 2016; 62(2):234-44. PubMed ID: 30452215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
    Pilger E; Schmid P; Goebel R
    Acta Med Austriaca; 1978; 5(3):91-5. PubMed ID: 752221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects.
    Czyzyk A; Lao B; Bartosiewicz W; Szczepanik Z; Orlowska K
    Diabetologia; 1978 Feb; 14(2):89-94. PubMed ID: 631460
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic and antimalarial biguanide drugs are metal-interactive antiproteolytic agents.
    Sweeney D; Raymer ML; Lockwood TD
    Biochem Pharmacol; 2003 Aug; 66(4):663-77. PubMed ID: 12906931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced secretion of glucagon-like peptide 1 by biguanide compounds.
    Yasuda N; Inoue T; Nagakura T; Yamazaki K; Kira K; Saeki T; Tanaka I
    Biochem Biophys Res Commun; 2002 Nov; 298(5):779-84. PubMed ID: 12419322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
    Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
    Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energy metabolism modulation by biguanides in comparison with rotenone in rat liver and heart.
    Heinz S; Freyberger A; Lawrenz B; Schladt L; Schmuck G; Ellinger-Ziegelbauer H
    Arch Toxicol; 2019 Sep; 93(9):2603-2615. PubMed ID: 31324951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enhancement of oxidative DNA damage by anti-diabetic metformin, buformin, and phenformin, via nitrogen-centered radicals.
    Ohnishi S; Mizutani H; Kawanishi S
    Free Radic Res; 2016 Aug; 50(8):929-37. PubMed ID: 27328723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1976 Mar; 54(6):283-5. PubMed ID: 177803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biguanides in oral antidiabetic therapy: indications and limitations].
    Gregorio F; Filipponi P
    Medicina (Firenze); 1988; 8(3):262-8. PubMed ID: 3231038
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.
    Wang DS; Kusuhara H; Kato Y; Jonker JW; Schinkel AH; Sugiyama Y
    Mol Pharmacol; 2003 Apr; 63(4):844-8. PubMed ID: 12644585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine deprivation enhances antineoplastic activity of biguanides.
    Gravel SP; Hulea L; Toban N; Birman E; Blouin MJ; Zakikhani M; Zhao Y; Topisirovic I; St-Pierre J; Pollak M
    Cancer Res; 2014 Dec; 74(24):7521-33. PubMed ID: 25377470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biguanides: reasons for withdrawal of drugs and remaining indications].
    Bolzano K
    Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.